We are proud to share the recent “TG1 Medicina” report highlighting a revolution in the field of neuroscience. The segment focuses on the Deep Brain Stimulation (DBS) device for treating Parkinson’s symptoms, developed by Newronika.

This technological excellence is the result of a strategic synergy: Newronika is a portfolio company of Enea Tech and Biomedical, supported through the Fund for Industrial and Biomedical Research and Development established by the Ministry of Enterprises and Made in Italy, and Newronika spin off company of University of Milano and Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

This is a concrete example of how supporting Italian research can transform into life-saving solutions that are designed to radically improve the daily lives of patients.

See the full video here:
‍